Latest Pharmacy News
Fluvoxamine Does Not Improve Time to Sustained Recovery in Mild COVID-19
posted January 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Racial/Ethnic Minorities Less Likely to Use Newer Antiseizure Meds
posted January 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
Risankizumab Safe, Effective at 52 Weeks for Psoriatic Arthritis
posted January 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
Antipsychotics Increasingly Being Prescribed to Children
posted January 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
Nonmedical Expense Reimbursement May Make Cancer Trials More Accessible .jpg)
Rates of Drug Use-Associated Infective Endocarditis Declined From 2020 to 2022 
Study Looks at Approaches to Prescribing Obesity Medications for Older Adults 
Nonpharmacologic Therapy Cuts Opioid Use Disorder Risk With Low Back Pain Pharmacy Conference Highlights
Pharmacy Monthly Briefings
Pharmacy Conference News
Stay Connected
